"Phosphocreatine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An endogenous substance found mainly in skeletal muscle of vertebrates. It has been tried in the treatment of cardiac disorders and has been added to cardioplegic solutions. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1996)
| Descriptor ID |
D010725
|
| MeSH Number(s) |
D12.125.373.603 D12.125.740.675
|
| Concept/Terms |
Phosphocreatine- Phosphocreatine
- Phosphorylcreatine
- Creatine Phosphate
- Phosphate, Creatine
|
Below are MeSH descriptors whose meaning is more general than "Phosphocreatine".
Below are MeSH descriptors whose meaning is more specific than "Phosphocreatine".
This graph shows the total number of publications written about "Phosphocreatine" by people in this website by year, and whether "Phosphocreatine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1998 | 0 | 1 | 1 |
| 2000 | 0 | 2 | 2 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Phosphocreatine" by people in Profiles.
-
Maqdasy S, Lecoutre S, Renzi G, Frendo-Cumbo S, Rizo-Roca D, Moritz T, Juvany M, Hodek O, Gao H, Couchet M, Witting M, Kerr A, Bergo MO, Choudhury RP, Aouadi M, Zierath JR, Krook A, Mejhert N, Ryd?n M. Impaired phosphocreatine metabolism in white adipocytes promotes inflammation. Nat Metab. 2022 02; 4(2):190-202.
-
Atag?n MI, Sikoglu EM, Can SS, Ugurlu GK, Kaymak SU, ?ayk?yl? A, Algin O, Phillips ML, Moore CM, ?ng?r D. Neurochemical differences between bipolar disorder type I and II in superior temporal cortices: A proton magnetic resonance spectroscopy study. J Affect Disord. 2018 08 01; 235:15-19.
-
Hamarneh SR, Murphy CA, Shih CW, Frontera W, Torriani M, Irazoqui JE, Makimura H. Relationship between serum IGF-1 and skeletal muscle IGF-1 mRNA expression to phosphocreatine recovery after exercise in obese men with reduced GH. J Clin Endocrinol Metab. 2015 Feb; 100(2):617-25.
-
Sikoglu EM, Jensen JE, Vitaliano G, Liso Navarro AA, Renshaw PF, Frazier JA, Moore CM. Bioenergetic measurements in children with bipolar disorder: a pilot 31P magnetic resonance spectroscopy study. PLoS One. 2013; 8(1):e54536.
-
Larsen RG, Callahan DM, Foulis SA, Kent-Braun JA. Age-related changes in oxidative capacity differ between locomotory muscles and are associated with physical activity behavior. Appl Physiol Nutr Metab. 2012 Feb; 37(1):88-99.
-
Greenman RL, Wang X, Smithline HA. Simultaneous acquisition of phosphocreatine and inorganic phosphate images for Pi:PCr ratio mapping using a RARE sequence with chemically selective interleaving. Magn Reson Imaging. 2011 Oct; 29(8):1138-44.
-
Greenman RL, Smithline HA. The feasibility of measuring phosphocreatine recovery kinetics in muscle using a single-shot (31)P RARE MRI sequence. Acad Radiol. 2011 Jul; 18(7):917-23.
-
Lanza IR, Tevald MA, Befroy DE, Kent-Braun JA. Intracellular energetics and critical PO2 in resting ischemic human skeletal muscle in vivo. Am J Physiol Regul Integr Comp Physiol. 2010 Nov; 299(5):R1415-22.
-
Tevald MA, Foulis SA, Lanza IR, Kent-Braun JA. Lower energy cost of skeletal muscle contractions in older humans. Am J Physiol Regul Integr Comp Physiol. 2010 Mar; 298(3):R729-39.
-
Larsen RG, Callahan DM, Foulis SA, Kent-Braun JA. In vivo oxidative capacity varies with muscle and training status in young adults. J Appl Physiol (1985). 2009 Sep; 107(3):873-9.